coumarin has been researched along with 2019 Novel Coronavirus Disease in 2 studies
2H-chromen-2-one: coumarin derivative
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chidambaram, SK | 1 |
| Ali, D | 1 |
| Alarifi, S | 1 |
| Radhakrishnan, S | 1 |
| Akbar, I | 1 |
| Ihssen, J | 1 |
| Faccio, G | 1 |
| Yao, C | 1 |
| Sirec, T | 1 |
| Spitz, U | 1 |
2 other studies available for coumarin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2.
Topics: Antiviral Agents; Betacoronavirus; Binding Sites; China; Coronavirus Infections; Coumarins; COVID-19 | 2020 |
Fluorogenic
Topics: Antiviral Agents; Coronavirus 3C Proteases; Coumarins; COVID-19; COVID-19 Drug Treatment; Drug Disco | 2021 |